SZSE:301093 (China)
Â
Class A
Â¥
22.62
(+0.27%)
Dec 25
Business Description
Jiangsu Hualan New Pharmaceutical Material Co Ltd
ISIN : CNE100004YH2
Share Class Description:
SZSE:301093: Class ACompare
Compare
Traded in other countries / regions
301093.China IPO Date
2021-11-01Description
Jiangsu Hualan New Pharmaceutical Material Co Ltd is engaged in the direct contact with the research and development, production and sales of packaging materials for injection drugs. The company's main products are medicinal sealing elastomers such as film-coated rubber plugs for high and middle end injections, conventional rubber plugs, pre-filled pistons, and silicone seals.
Financial Strength
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 497.92 | |||||
| Equity-to-Asset | 0.9 | |||||
| Debt-to-EBITDA | 0.02 | |||||
| Interest Coverage | 60 | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | 8.38 | |||||
| Beneish M-Score | -2.59 | |||||
| WACC vs ROIC | ||||||
Growth Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 1.2 | |||||
| 3-Year EBITDA Growth Rate | 1 | |||||
| 3-Year EPS without NRI Growth Rate | -15.8 | |||||
| 3-Year Book Growth Rate | 67.1 | |||||
| Future 3-5Y EPS without NRI Growth Rate | 54.4 | |||||
| Future 3-5Y Total Revenue Growth Rate | 23.1 |
Momentum Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 31.61 | |||||
| 9-Day RSI | 36.15 | |||||
| 14-Day RSI | 41.29 | |||||
| 6-1 Month Momentum % | 13.69 | |||||
| 12-1 Month Momentum % | -28.01 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 10.55 | |||||
| Quick Ratio | 9.86 | |||||
| Cash Ratio | 4.27 | |||||
| Days Inventory | 108.22 | |||||
| Days Sales Outstanding | 100.4 | |||||
| Days Payable | 116.8 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 2.66 | |||||
| Dividend Payout Ratio | 1.04 | |||||
| Forward Dividend Yield % | 2.66 | |||||
| 5-Year Yield-on-Cost % | 2.67 | |||||
| 3-Year Average Share Buyback Ratio | -10.4 | |||||
| Shareholder Yield % | 3 |
Profitability Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 38.92 | |||||
| Operating Margin % | 9.37 | |||||
| Net Margin % | 13.66 | |||||
| FCF Margin % | 2.35 | |||||
| ROE % | 3.44 | |||||
| ROA % | 3.13 | |||||
| ROIC % | 2.67 | |||||
| ROC (Joel Greenblatt) % | 6.17 | |||||
| ROCE % | 3.85 | |||||
| Years of Profitability over Past 10-Year | 7 |
GF Value Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 37.02 | |||||
| Forward PE Ratio | 16.76 | |||||
| PE Ratio without NRI | 39.27 | |||||
| PS Ratio | 5.01 | |||||
| PB Ratio | 1.28 | |||||
| Price-to-Tangible-Book | 1.32 | |||||
| Price-to-Free-Cash-Flow | 203.08 | |||||
| Price-to-Operating-Cash-Flow | 13.96 | |||||
| EV-to-EBIT | 23.49 | |||||
| EV-to-EBITDA | 23.49 | |||||
| EV-to-Revenue | 3.7 | |||||
| EV-to-FCF | 157.52 | |||||
| Price-to-Graham-Number | 1.52 | |||||
| Price-to-Net-Current-Asset-Value | 1.98 | |||||
| Price-to-Net-Cash | 6.52 | |||||
| Earnings Yield (Greenblatt) % | 4.26 | |||||
| FCF Yield % | 0.48 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Jiangsu Hualan New Pharmaceutical Material Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ¥) | 591.965 | ||
| EPS (TTM) (Â¥) | 0.611 | ||
| Beta | 1.17 | ||
| Volatility % | 42.92 | ||
| 14-Day RSI | 41.29 | ||
| 14-Day ATR (Â¥) | 0.768159 | ||
| 20-Day SMA (Â¥) | 23.6875 | ||
| 12-1 Month Momentum % | -28.01 | ||
| 52-Week Range (Â¥) | 17.12 - 32.54 | ||
| Shares Outstanding (Mil) | 127.08 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Jiangsu Hualan New Pharmaceutical Material Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Jiangsu Hualan New Pharmaceutical Material Co Ltd Stock Events
| Event | Date | Price(Â¥) | ||
|---|---|---|---|---|
| No Event Data | ||||
Jiangsu Hualan New Pharmaceutical Material Co Ltd Frequently Asked Questions
What is Jiangsu Hualan New Pharmaceutical Material Co Ltd(SZSE:301093)'s stock price today?
The current price of SZSE:301093 is ¥22.62. The 52 week high of SZSE:301093 is ¥32.54 and 52 week low is ¥17.12.
When is next earnings date of Jiangsu Hualan New Pharmaceutical Material Co Ltd(SZSE:301093)?
The next earnings date of Jiangsu Hualan New Pharmaceutical Material Co Ltd(SZSE:301093) is .
Does Jiangsu Hualan New Pharmaceutical Material Co Ltd(SZSE:301093) pay dividends? If so, how much?
The Dividend Yield %  of Jiangsu Hualan New Pharmaceutical Material Co Ltd(SZSE:301093) is 2.66% (As of Today), Highest Dividend Payout Ratio of Jiangsu Hualan New Pharmaceutical Material Co Ltd(SZSE:301093) was 1.47. The lowest was 0.62. And the median was 1.05. The  Forward Dividend Yield % of Jiangsu Hualan New Pharmaceutical Material Co Ltd(SZSE:301093) is 2.66%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers